Imatinib TDM in GIST
Condition(s):Gastrointestinal Stromal TumorsLast Updated:January 12, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Gastrointestinal Stromal TumorsLast Updated:January 12, 2024Not yet recruiting
Condition(s):Metastatic Gastrointestinal Stromal Tumor (GIST); C-KIT Mutation; Advanced Gastrointestinal Stromal Tumor (GIST)Last Updated:September 1, 2023Recruiting
Condition(s):Plexiform NeurofibromasLast Updated:April 8, 2019Terminated
Condition(s):Gastrointestinal Stromal Tumor of RectumLast Updated:August 1, 2023Not yet recruiting
Condition(s):Maximum Tolerated Dose; GIST; Metastatic Adult Soft Tissue Sarcoma; Drug Toxicity; Drug UseLast Updated:March 27, 2023Active, not recruiting
Condition(s):ARDS; Acute Respiratory Distress Syndrome; Covid19; Endothelial Dysfunction; Pulmonary EdemaLast Updated:January 23, 2023Terminated
Condition(s):GIST and CMLLast Updated:January 31, 2024Active, not recruiting
Condition(s):Leukemia, Myeloid, Chronic-PhaseLast Updated:March 23, 2018Unknown status
Condition(s):Papillary Thyroid CancerLast Updated:February 2, 2023Recruiting
Condition(s):Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, BCR/ABL-Positive; Chronic Myeloid Leukemia in RemissionLast Updated:October 23, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.